Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more.

Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Annals of internal medicine (Impact Factor: 17.81). 02/2006; 144(1):10-20. DOI: 10.7326/0003-4819-144-1-200601030-00005
Source: PubMed


Exercise rehabilitation programs increase treadmill walking performance in patients with peripheral arterial disease (PAD) and intermittent claudication. However, it is unknown whether patients with PAD who walk for exercise regularly have less functional decline than those with less walking activity.
To determine whether patients with PAD who report that they walk for exercise 3 or more times per week have less annual functional decline than those who walk for exercise less frequently.
Prospective cohort study with a median follow-up of 36 months (interquartile range, 24 to 36 months).
Academic medical center.
417 men and women with PAD.
Participants were classified at baseline and annually according to the number of times they reportedly walked for exercise each week. Functional assessments (6-minute walk distance, 4-meter walking speed, summary performance score) were measured at baseline and annually. Results were adjusted for age, sex, ethnicity, comorbid conditions, body mass index, ankle-brachial index, education, leg symptoms, cigarette use, geriatric depression score, previous year's level of functioning, and patterns of missing data.
Compared with those who exercised less frequently, patients who walked for exercise 3 or more times per week had a significantly smaller average annual decline in 6-minute walking distance (-48.0 feet per year compared with -56.6 feet per year for those who walked 1 to 2 times per week and -79.4 feet per year for nonexercisers; P for trend = 0.037). Patients who walked for exercise at least 3 times per week experienced a smaller average annual decline in the usual-paced 4-meter walking velocity (-0.014 m/s per year compared with -0.022 m/s per year for those who walked 1 to 2 times per week and -0.045 m/s per year for nonexercisers; P = 0.005). Similar findings were observed for the fast-paced 4-meter walk. The subset of asymptomatic patients who walked for exercise 3 or more times per week had annual declines in 6-minute walking performance (P = 0.107), normal-paced walking velocity (P = 0.065), and the summary performance score (P = 0.115); however, these declines were smaller than those observed in asymptomatic participants who walked fewer than 3 times per week.
Because this was an observational study, associations reported here cannot be construed as causal relationships. Sample sizes for subgroup analyses were small, which limited statistical power.
Among patients with PAD, self-directed walking exercise performed at least 3 times weekly is associated with significantly less functional decline during the subsequent year. Similar trends were observed in the subset of asymptomatic patients with PAD. These findings may be particularly important for the numerous patients with PAD who do not have access to supervised walking exercise programs.

Download full-text


Available from: Gary J Martin, Mar 28, 2014
  • Source
    • "Lavoie et al. (2004) found evidence for this hypothesis in myocardial ischemia patients with depressive symptomatology who underwent exercise stress tests. On the other hand, worse performance on the treadmill exercise test may be indicative for poor daily functioning and more functional decline (McDermott et al., 2006). Daily functioning, and more specifically walking behaviour seems to be of vital importance to help reduce the cardiovascular complications and mortality, even in populations with severe limitations (Smith et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Depressive symptoms are associated with poor prognosis in coronary artery disease, but there is a paucity of research on these symptoms in peripheral arterial disease (PAD). We examined the clinical correlates and 18-month course of depressive symptoms in PAD patients. 166 patients with symptomatic lower-extremity PAD (39% women; M age=64.9 +/- 10 years) completed the 10-item Center for Epidemiological Studies Depression scale. A score > or =4 indicates clinically relevant depressive symptoms. Depressive symptoms were re-assessed at 6, 12, and 18 months follow-up. Ankle-brachial index (ABI) and treadmill walking distance were used to assess PAD severity. At baseline, depressive symptoms (CES-D > or =4) were present in 16% of the patients. Depressed patients performed worse regarding pain free (p=0.003) and maximum (p=0.005) walking distance. After adjusting for age, sex, education, ABI, psychotropic medication use, cardiovascular risk factors, and comorbidity, depressive symptoms remained stable in initially depressed patients. Using mixed modelling, three subgroups were identified in the total sample. The majority of PAD patients did not have depressive symptoms (58%), but there were two groups who persistently experienced either subclinical (27%) or clinically manifest (15%) depressive symptoms. Only baseline data of ABI and treadmill walking performance were available. Depressive symptomatology was present in a substantial number of PAD patients, tended to be stable, and was associated with reduced walking distance. These apparently evident results are overlooked thus far in this patient group and deserve further attention in research and clinical care.
    Journal of Affective Disorders 02/2008; 110(1-2):27-35. DOI:10.1016/j.jad.2007.12.238 · 3.38 Impact Factor
  • Source
    • "Supervised exercise training is recommended for a minimum of 30–45 minutes in sessions performed at least 3 times per week for a minimum of 12 weeks (Hirsch et al 2006) and preferably for 6 months or longer (Gardner et al 1995). Among persons with PAD, self-directed walking exercise performed at least 3 times weekly is associated with significantly less functional decline during the subsequent year (McDermott et al 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Smoking should be stopped and hypertension, diabetes mellitus, dyslipidemia, and hypothyroidism treated in elderly patients with peripheral arterial disease (PAD) of the lower extremities. Statins reduce the incidence of intermittent claudication and improve exercise duration until the onset of intermittent claudication in patients with PAD and hypercholesterolemia. Antiplatelet drugs such as aspirin or clopidogrel, especially clopidogrel, angiotensin-converting enzyme inhibitors, and statins should be given to all elderly patients with PAD without contraindications to these drugs. Beta blockers should be given if coronary artery disease is present. Exercise rehabilitation programs and cilostazol increase exercise time until intermittent claudication develops. Chelation therapy should be avoided. Indications for lower extremity percutaneous transluminal angioplasty or bypass surgery are (1) incapacitating claudication in patients interfering with work or lifestyle; (2) limb salvage in patients with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, and/or infection or gangrene; and (3) vasculogenic impotence.
    Clinical Interventions in Aging 02/2007; 2(4):645-54. · 2.08 Impact Factor
  • Source
    • "Recent data has shown that exercise has benefits for patients with peripheral arterial disease [9], yet ironically, exercise becomes limited due to pain and fatigue associated with the disease. During exercise, the sympathetic nervous system mediates vasoconstriction in both unutilized muscle and viscera to redistribute blood flow to exercising muscles [10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Peripheral arterial disease in the legs represents a subset of atherosclerosis that manifests a particularly sinister profile. A predominance of sympathetic activity in the periphery favors the development of neurogenic atherosclerosis. Atherosclerosis may then produce flow derangements and decreased physical activity that serves to escalate sympathetic bias in a vicious cycle. Restoration of normal flow in peripheral arterial disease may not only produce local benefit due to improved perfusion, but also represent a gateway to correcting many systemic conditions that may at first glance appear unrelated but share a common etiology of autonomic dysfunction, such as gout, acute coronary syndromes, stroke, sleep apnea, arrhythmias, depression, erectile dysfunction, inflammation, hypercoagulability, sleep disorders, bowel dysfunction, renal failure, and aging.
    Medical Hypotheses 02/2006; 67(4):947-50. DOI:10.1016/j.mehy.2006.03.027 · 1.07 Impact Factor
Show more